Literature DB >> 11805565

What is the impact of fecal incontinence on quality of life?

J Rothbarth1, W A Bemelman, W J Meijerink, A M Stiggelbout, A H Zwinderman, M E Buyze-Westerweel, J B Delemarre.   

Abstract

PURPOSE: The objective of this study was to determine at what point fecal incontinence affects quality of life.
METHODS: In 35 patients who had anterior sphincter repair for fecal incontinence as a result of obstetric injury, continence evaluated by the Wexner score was compared with validated quality of life tests (Gastrointestinal Quality of Life Index and Medical Outcomes Study Short-Form General Health Survey). The questionnaires were sent by mail. Thirty-two patients responded. The Wexner score (0-20) was correlated with the Gastrointestinal Quality of Life Index and the Medical Outcomes Study Short-Form General Health Survey and matched with those of reference groups.
RESULTS: The mean Wexner score was 8.8, corresponding with losing stools between once a week and once a month. The mean Gastrointestinal Quality of Life Index score was 105 (range, 48-136), which is significantly lower than the score found in a reference group of normal individuals. Medical Outcomes Study Short-Form General Health Survey scores were significantly lower in all six dimensions compared with the reference group. A Wexner score of 9 or higher was associated with a Gastrointestinal Quality of Life Index score of less than 105, which implies that patients were less mobile in the community and were confined to their homes. A similar correlation was found between a Wexner score higher than 9 and the Medical Outcomes Study Short-Form General Health Survey.
CONCLUSIONS: A Wexner score of 9 or higher indicates a significant impairment of quality of life and can therefore be used in decision making.

Entities:  

Mesh:

Year:  2001        PMID: 11805565     DOI: 10.1007/bf02234823

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  66 in total

1.  Meta-analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence.

Authors:  Emile Tan; Nye-Thane Ngo; Ara Darzi; Michael Shenouda; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

2.  Sacral neuromodulation for the treatment of faecal incontinence in a patient with organophosphate poisoning.

Authors:  M Tayyab; R Arsalani-Zadeh; S Ullah; S Mehmood; P Waudby; G S Duthie
Journal:  Tech Coloproctol       Date:  2010-08-04       Impact factor: 3.781

3.  Midterm functional results of taTME with neuromapping for low rectal cancer.

Authors:  W Kneist; N Wachter; M Paschold; D W Kauff; A D Rink; H Lang
Journal:  Tech Coloproctol       Date:  2015-11-11       Impact factor: 3.781

4.  Anatomical outcome and quality of life following posterior vaginal wall prolapse repair using collagen xenograft.

Authors:  Daniel Altman; Annika López; Catharina Gustafsson; Christian Falconer; Johan Nordenstam; Jan Zetterström
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-05

5.  Outcome of overlapping anal sphincter repair after 3 months and after a mean of 80 months.

Authors:  Goran I Barisic; Zoran V Krivokapic; Velimir A Markovic; Milos A Popovic
Journal:  Int J Colorectal Dis       Date:  2005-04-14       Impact factor: 2.571

6.  St. Mark's incontinence score for assessment of anal incontinence following obstetric anal sphincter injuries (OASIS).

Authors:  Anne-Marie Roos; Abdul H Sultan; Ranee Thakar
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-12-12

7.  Does cesarean protect against fecal incontinence in primiparous women?

Authors:  Jeanne-Marie Guise; Sarah Hamilton Boyles; Patricia Osterweil; Hong Li; Karen B Eden; Motomi Mori
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-24

8.  Is there a role for concomitant pelvic floor repair in patients with sphincter defects in the treatment of fecal incontinence?

Authors:  Scott R Steele; Patrick Lee; Philip S Mullenix; Matthew J Martin; Eugene S Sullivan
Journal:  Int J Colorectal Dis       Date:  2005-08-02       Impact factor: 2.571

9.  Written versus oral disclosure of fecal and urinary incontinence in women with dual incontinence.

Authors:  Sara B Cichowski; Yuko M Komesu; Gena C Dunivan; Clifford Qualls; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2014-05-08       Impact factor: 2.894

10.  Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women.

Authors:  Yue-Xin Yang; Mei He; Gang Hu; Jie Wei; Philippe Pages; Xian-Hua Yang; Sophie Bourdu-Naturel
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.